Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Vermillion; NCGR, Isilon; Gelcompany, Max Planck Institute for Biochemistry; Linguamatics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion this week said that it will work with reimbursement services firm Premiere Source Diagnostics for the OVA1 triage ovarian cancer test.

In addition, the firm said that the US Bankruptcy Court in Delaware has approved the final fee application in its Chapter 11 reorganization case. The total professional fees and expenses were about $3.8 million, of which $2.7 million remained unpaid as of March 31.

Vermillion emerged from US Bankruptcy Protection in January — less than 10 months after filing for Chapter 11.


The National Center for Genome Resources is using Isilon's scale-out NAS to power its next-generation sequencing services, Isilon said this week. NCGR will use the storage resource for data generated by the eight Illumina Genome Analyzers it is using.


The Max Planck Institute for Biochemistry is using Gelcompany's HPE FlatTop Tower System for its protein analysis work. The system enables "higher resolution, reproducibility, and ease of use in 1D and 2D gel electrophoresis separations, said Australia-based Gelcompany.


Linguamatics said that its 2009 revenues exceeded $5 million, outperforming its target of 50 percent year-over-year growth.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.